更正：解密肝癌细胞对酪氨酸激酶抑制剂的耐药性：肝芯片模型揭示肿瘤内皮细胞机制的启示。

IF 6.1 2区工程技术 Q1 BIOCHEMICAL RESEARCH METHODS

Lab on a Chip Pub Date : 2024-10-31 DOI:10.1039/D4LC90093F

Madhu Shree Poddar, Yu-De Chu, Chau-Ting Yeh and Cheng-Hsien Liu

引用次数: 0

摘要

对 Madhu Shree Poddar 等人撰写的《解读肝癌细胞对酪氨酸激酶抑制剂的耐药性：从肝片上模型揭示肿瘤内皮细胞机制的启示》的更正，《实验室芯片》，2024 年，24 期，3668-3678，https://doi.org/10.1039/D4LC00238E。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction: Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms

Correction for ‘Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms’ by Madhu Shree Poddar et al., Lab Chip, 2024, 24, 3668–3678, https://doi.org/10.1039/D4LC00238E.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Lab on a Chip 工程技术-化学综合

CiteScore

11.10

自引率

8.20%

发文量

434

审稿时长

2.6 months

期刊介绍： Lab on a Chip is the premiere journal that publishes cutting-edge research in the field of miniaturization. By their very nature, microfluidic/nanofluidic/miniaturized systems are at the intersection of disciplines, spanning fundamental research to high-end application, which is reflected by the broad readership of the journal. Lab on a Chip publishes two types of papers on original research: full-length research papers and communications. Papers should demonstrate innovations, which can come from technical advancements or applications addressing pressing needs in globally important areas. The journal also publishes Comments, Reviews, and Perspectives.